These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 919782

  • 1. An evaluation of cervical cytological screening in the University Teaching Hospital, Lusaka.
    O'Dowd MJ, Grech ES, Tsirkina GA, Zeigler O.
    Med J Zambia; 1977; 11(4):117-21. PubMed ID: 919782
    [Abstract] [Full Text] [Related]

  • 2. Cervical cytology in Zambia.
    Grech ES, O'Dowd MJ, Tsirkina GA, Zeigler O.
    Med J Zambia; 1977; 11(4):112-7. PubMed ID: 919781
    [Abstract] [Full Text] [Related]

  • 3. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY, Stanbridge EJ.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [Abstract] [Full Text] [Related]

  • 4. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 5. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
    Sankaranarayanan R, Wesley R, Somanathan T, Dhakad N, Shyamalakumary B, Amma NS, Parkin DM, Nair MK.
    Cancer; 1998 Nov 15; 83(10):2150-6. PubMed ID: 9827719
    [Abstract] [Full Text] [Related]

  • 6. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
    Misra JS, Gupta HP, Das V.
    Diagn Cytopathol; 2004 Dec 15; 31(6):376-9. PubMed ID: 15540174
    [Abstract] [Full Text] [Related]

  • 7. The cervical smear pattern in patients with chronic pelvic inflammatory disease.
    Abdul MA, Shittu SO, Randawa JA, Shehu MS.
    Niger J Clin Pract; 2009 Sep 15; 12(3):289-93. PubMed ID: 19803028
    [Abstract] [Full Text] [Related]

  • 8. Results of longterm hospital based cytological screening in asymptomatic women.
    Misra JS, Singh U.
    Diagn Cytopathol; 2006 Mar 15; 34(3):184-7. PubMed ID: 16470854
    [Abstract] [Full Text] [Related]

  • 9. Cervical cancer screening; need among hospital inpatients.
    Boyce J, Fruchter R, Thompson M, Conly C, Jones M, Maloney J, Bloomfield R.
    N Y State J Med; 1981 Mar 15; 81(3):331-3. PubMed ID: 6938820
    [No Abstract] [Full Text] [Related]

  • 10. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE, Hagen B, Hagmar B, Iversen OE, Juvkam KH, Steen R, Thoresen S, Hareide B.
    Tidsskr Nor Laegeforen; 2007 Jun 28; 127(13):1782-5. PubMed ID: 17599128
    [Abstract] [Full Text] [Related]

  • 11. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ, Chirenje ZM.
    Cent Afr J Med; 1997 Sep 28; 43(9):246-51. PubMed ID: 9509642
    [Abstract] [Full Text] [Related]

  • 12. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A, Phillips N, Kan L, Matisic J, Benedet L, Towers L.
    J Med Screen; 2005 Sep 28; 12(1):7-11. PubMed ID: 15814014
    [Abstract] [Full Text] [Related]

  • 13. Cytological screening for precancerous lesions of the cervix.
    Sng I.
    Singapore Med J; 1987 Oct 28; 28(5):415-21. PubMed ID: 3433107
    [No Abstract] [Full Text] [Related]

  • 14. A review of the epidemiology of cancers at the University Teaching Hospital, Lusaka, Zambia.
    Bowa K, Wood C, Chao A, Chintu C, Mudenda V, Chikwenya M.
    Trop Doct; 2009 Jan 28; 39(1):5-7. PubMed ID: 19211410
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria.
    Konje JC, Otolorin EO, Ogunniyi JO, Obisesan KA, Ladipo OA.
    Afr J Med Med Sci; 1991 Mar 28; 20(1):29-34. PubMed ID: 1905467
    [Abstract] [Full Text] [Related]

  • 19. Cancer of the cervix.
    Olatunji AO, Sule-Odu AO.
    Niger Postgrad Med J; 2005 Dec 28; 12(4):308-11. PubMed ID: 16380745
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.